The discovery could lead to more targeted and effective treatments for certain lung and prostate cancers, researchers said. Researchers, including one of Indian-origin, have identified two new cancer-causing gene mutations that may be susceptible to existing cancer-fighting drugs. The discovery could lead to more targeted and effective treatments for certain lung and prostate cancers, researchers said.
Researchers said that cancers with the newly discovered mutations in the MCM8 and MCM9 genes likely will respond extremely favorably to the same chemotherapy drugs that have already proven effective against breast cancers with the well-known BRCA1 and BRCA2 gene mutations. "One of the biggest problems in cancer is that we hit everything with the same hammer, and consequently some cancers are responsive and others are not," said lead researcher Anindya Dutta of University of Virginia…
